Replies to post #194033 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Large pharma have forgone Europe pricing and thus revenue because they wanted U.S. revenue and primary positioning on various indications, there’s no way in hell an expert like you would even know when LP (ceo of small biotech) would unblind, because:

If she had been told of (any potential) stat sig in 2015 she would have had to decide whether to stay blinded for higher/any European revenue versus trying her luck at u.s. approval on lesser maturity.

She told people in very late 2014 on the record, topline likely by early 2016.

Off the record, a couple weeks later, she supposedly told several people she would not stop trial until primary endpoint reached.

Good for you if you figured out what to do, but quit shaming people when you very well could have been wrong.

[Extremist223]

Okay top gun 10-4.

[Doc logic]

maverick_1,

Not everyone lost track of what was going on. I am just not an investment purist. I have had other motives in the mix all along and that included staying the course and adding in later at a much lower price point which I have done and remain flexible enough to continue to do. Staying flexible in life and with high risk investments works pretty well for me especially as those investments are matched with improved confidence that comes from increasing evidence of improved outcomes over time. Best wishes.

[HappyLibrarian]

Shareholders could not believe management could get away with being this unethical at worst or irresponsible at best for this long without someone imposing accountability. Each year we thought something has had to give.

If management had not misled us about how long they were dragging out this trial and any game changing news, we would have sold and bought in at lower prices.

They deliberately made it look like good news was always just six months away, as we averaged down and they kept getting a bigger and bigger ownership share.

[biosectinvestor]

Are you talking about your own investing or mine?

For me, I'm just fine bub. My investment portfolio is managing quite well. People who don't know how to invest, should not be anywhere near small biotech compnanies. If you're investing mortgage money or borrowing from your credit cards to invest in any of these companies, then you don't know what your doing. Single stock investing is even more of a disaster.

But that doesn't mean what happens in just about every one of these companies, unexpected delays, lawsuits, annoyances of every kind and manner, are due to bad investing or evil management.

The world is filled with all kinds of shysters and many of them work in the investor world as speculators and they look to "create" value with their own shenanigans with these companies.

I don't trust any single one of them, and that includes ESPECIALLY people like Woodford (NW), who is an investor, of the very same sort. No one is a white knight at that level, they are all out for themselves and the people invested in their fund, not the other investors.

As for your criticism of other investors ... I think a good investor focuses on managing their OWN investments. People who rant on bulletin boards are typically not good investors. Just an opinion. Ranting doesn't make one's portfolio go up, any more than chatter about the science.

But ranting does make investments go down. Which is another way that some investors clearly make money, such as hedge funds. I just wish they'd be honest... but that would screw up the game for them.